The world�s leading bioscience experts
are coming to Atlantic Canada, and specifically to
Newfoundland and Labrador throughout the month of
September, to forge strategic business and research
alliances with their Atlantic Canadian counterparts.
Nearly 50 international bioscience
leaders will take part in a series of activities, hosted
by each of the four Atlantic provinces throughout the
month of September, including one-on-one business
meetings, site tours, educational sessions and
networking events.
The 2009 Pan-Atlantic Incoming
BioPartnering Mission builds on the strong results of
the inaugural visit by international companies and
research organizations to Atlantic Canada in 2008. The
incoming mission is funded by the provincial and federal
governments through the Canada/Atlantic Provinces
Agreement on International Business Development (IBDA).
"The Government of Canada is committed
to the development of Atlantic Canada�s bioscience
industry," said the Honourable Keith Ashfield, Minister
of State (Atlantic Canada Opportunities Agency). "Our
investment in this business mission will help support
the growth of this industry, which is important to
Atlantic Canada�s economy, by raising the sector�s
international profile, encouraging commercialization and
attracting foreign investment."
"The life science industry in
Newfoundland and Labrador, while in its early stages of
development, shows incredible promise," said the
Honourable Shawn Skinner, Minister of Innovation, Trade
and Rural Development. "Significant research discoveries
have been made by local researchers and there are
several emerging companies that are in the process of
commercializing their products and services. Supporting
research collaborations and assisting with international
business development through the bio-partnering
initiative is integral to assisting our local industry."
Atlantic Canada�s bioscience industry
is a hotbed of innovation research and business
opportunities, consisting of over 100 companies and
employing thousands of Atlantic Canadians. The
industry�s sales, employment figures, and research and
development (R&D) are forecast to increase significantly
over the next five years.
As a result of last year�s mission,
during which 26 foreign companies travelled to Atlantic
Canada, researchers from Memorial University in St.
John�s, Newfoundland and Labrador, joined with St.
John's-based Newfound Genomics, and Boston-based
PGxHealth Ltd. to put Memorial�s diagnostic test for a
lethal heart condition within easy reach of doctors and
patients. According to Dr. Wayne Gulliver of Newfound
Genomics, the 2008 biopartnering mission served as a
catalyst for bringing the parties together to complete
this deal. "The biopartnering project gave us the
opportunity to bring are partners in from the United
States to our location in Newfoundland to complete the
details of our agreement. In turn, we were able to
solidify our relationship and get our diagnostics test
into the market much sooner than we originally planned."
The 2009 incoming mission is being
organized by BioAtlantech, the lead agency for
New Brunswick�s bio-industries, in partnership with its
counterparts in the three other Atlantic Provinces.
Creating awareness of Atlantic Canada�s bioscience
capabilities both nationally and internationally,
finding outlets for innovative products and attracting
investments to the region through R&D partnerships are
important goals for these regional stakeholders.
The mission�s events are designed to
showcase Atlantic Canada�s bioscience industry and to
build focused international business and research
partnerships. This collaboration can lead to new product
development, licensing agreements for intellectual
property, R&D projects and increased export sales for
Atlantic Canada�s bioscience companies and research
organizations.
A total of $217,440 in funding for the
inbound trade mission is being provided through the
IBDA. The IBDA is a federal/provincial agreement between
the Government of Canada (ACOA, Foreign Affairs and
International Trade Canada, and Industry Canada) and the
four provincial governments in Atlantic Canada, and is
designed to help Atlantic Canadian businesses enter,
explore and succeed in international markets. The IBDA
is the leading component of a pan-Atlantic effort to
foster business relations, attract foreign investment
and nurture technological co-operation.
- 30 -
Media contacts:
Following is the list of the Atlantic
Canadian companies and organizations participating in
the 2009 Pan-Atlantic Incoming BioParterning Mission:
New Brunswick
Atlantic Agri-Food Associates,
Williamstown
Chatham Biotec Ltd., Riverview
Coastal Zones Research Institute,
Shippagan
LuminUltra Technologies Ltd.,
Fredericton
Screening Devices Canada Ltd.,
Hatfield Point
Solanum Genomics, Fredericton
Sylvar Technologies/Forest Protection
Ltd, Fredericton
Newfoundland and Labrador
ICUS, St. John�s
Memorial University of Newfoundland �
Population Therapeutics Research Group, St. John�s
Memorial University of Newfoundland �
Ocean Sciences Centre, St. John�s
Nexus Clinical Research Inc., St.
John�s
Nova Scotia
Acadian Seaplants Ltd., Dartmouth
Dalhousie University, Halifax
National Research Council Institute
for Biodiagnostics (Atlantic), Halifax
Prince Edward Island
Chemaphor Inc., Charlottetown
Nautilus Biosciences
Canada, Charlottetown
Stirling Products Canada,
Charlottetown
Neurodyn Inc., Charlottetown
University of Prince Edward Island,
Charlottetown
National Research Council Institute
for Nutrisciences & Health., Charlottetown
2009 09 09 3:15 p.m.